SAN FRANCISCO, Aug. 7, 2014 (GLOBE NEWSWIRE) -- The Life Sciences Foundation, a nonprofit organization dedicated to biotech history, has appointed Scott Morrison as the new Chief Financial Officer and Director. Morrison replaces Victor Hebert as CFO, following Hebert's resignation from the position in June.
Morrison is the leader of Ernst & Young's U.S. Biotechnology and Medtech practice and a member of the firm's global industry steering committee. He has 28 years of local, national and global experience serving biotech and medtech clients.
"Scott has been a leader in the biotech industry since its early days. His financial savvy and deep knowledge of the community will be valuable resources for LSF," says Heather Erickson, President and CEO of the Life Sciences Foundation.
Morrison has worked on hundreds of public and private financings, including over 40 IPOs and over 100 follow-on offerings. He serves as the former chairman and current treasurer of the Bay Area Bioscience Center (BayBio), a founding board member of the Biotechnology Institute and past member of the Biotechnology Industry Organization (BIO) ECS board.
"Scott is a highly-respected financial stalwart of the biotech community, and LSF will benefit from his extensive industry knowledge and relationships," says Carl Feldbaum, chairman of the board of the Life Sciences Foundation and former president of the Biotechnology Industry Organization. "He's an entrepreneurial fourth generation San Franciscan with family business roots going back to the 1880's on Fishermen's Wharf."
The Life Sciences Foundation educates and inspires curious minds with the history and continuing significance of biotechnology. The foundation is collecting, preserving, and sharing firsthand information about the people, organizations and discoveries that define biotechnology and continue to shape the world in which we live.
More information is available at biotechhistory.org.